Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Lena Faust
Tuberculosis case notifications and outcomes in Peruvian prisons prior to and during the COVID-19 pandemic: a national-level interrupted time series analysis
Research in context An initial literature search on TB treatment outcomes in prisons, using the Embase and Medline databases (via Ovid) was conducted in September 2022, and updated in August 2023, including studies published from the year 2000 to the search date (August 2023 for the updated search), and used the search terms (prison∗ OR jail OR incarcerat∗ OR detain∗ OR detention OR deprived of liberty) AND (tuberculosis) AND (treatment outcome∗ OR treatment completion OR treatment success).
Improving measurement of tuberculosis care cascades to enhance people-centred care
FREE with registration! Log in or register to access the full article. References 1. Kruk, ME ∙ Gage, AD ∙ Arsenault, C ∙ et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution Lancet Glob Health. 2018; 6:e1196-e1252 2. Geldsetzer, P ∙ Manne-Goehler, J ∙ Marcus, ME ∙ et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults Lancet.
Canada is failing to track an ancient but deadly infectious disease
By Lena Faust All of us can name the biggest infectious disease killer in the world: COVID-19. But do we know which infectious disease bore this title prior to the COVID-19 pandemic? It was tuberculosis (TB) – a disease that continues to take over a million lives every year and was responsible for 1.5 million deaths in 2020 alone.
Canada is failing to track an ancient but deadly infectious disease
All of us can name the biggest infectious disease killer in the world: COVID-19. But do we know which infectious disease bore this title prior to the COVID-19 pandemic? It was tuberculosis (TB) – a disease that continues to take over a million lives every year and was responsible for 1.5 million deaths in 2020 alone.
The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis
Summary Background Novel skin-based tests for tuberculosis infection might present suitable alternatives to current tests; however, diagnostic performance of new tests compared with the purified protein derivative-tuberculin skin test (TST) or interferon-γ release assays (IGRA) needs systematic assessment.
A TB survivor’s crucial account of TB stigma - and what is needed to end it.
In her new book, Stigmatized, Handaa Enkh-Amgalan shares the story of her journey with TB, and her determination to use her voice and her experiences to speak out against TB stigma, in solidarity with others who are suffering. We owe Handaa a great debt of gratitude for sharing her story, and allowing us to learn from it.
The 100th Anniversary Of A Vaccine Against A Deadly Disease: Not A Cause For Celebration
Vaccines have been at the core of incredible global public health accomplishments, including the eradication of deadly diseases such as smallpox and polio, in most of the world’s regions. Last month, we marked World Immunization Week—a time to celebrate vaccines and the extraordinary progress that they have made possible in the fight against infectious diseases. Although it is important to reflect on vaccine success stories, we should also highlight where urgent vaccine gaps remain.
Canadian Tuberculosis R&D Funding in 2019 — Stop TB Canada
Highlights from the Treatment Action Group Tuberculosis Research Funding Report By Adam R. Houston and Lena Faust The Treatment Action Group (TAG)’s recently released report on tuberculosis (TB) research funding highlights the continued gap in spending on TB research, which continues to fall far behind the annual target of US$2 billion set at the 2018 United Nations High-Level Meeting on TB.
How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers
Abstract Background and aims Despite the World Health Organization (WHO)'s updated guidelines on tuberculosis (TB) preventive treatment, the scale‐up of TB preventive therapy remains low in many high‐burden countries (HBCs). We conducted a survey to better understand the current status of policy implementation and barriers for scale‐up.
The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
Childhood tuberculosis (TB) has hitherto been treated through estimation of pediatric doses through the crushing of adult pills, but the bitter taste of the pills and the inaccuracy of this dosing method presents a challenge for both patients and healthcare providers, leading to poor treatment outcomes. The TB Alliance therefore launched the Speeding Treatments to End Pediatric-Tuberculosis (STEP-TB) project to incentivize the introduction of pediatric Fixed-Dose Combinations (FDCs) of TB drugs.
HIV-related knowledge in Nigeria: a 2003-2013 trend analysis
When considering the implications of an analysis of trends in HIV-related knowledge, it is relevant to note at the outset that several Sub-Saharan African studies have reported the effectiveness of behaviour change interventions regarding HIV risk reduction and prevention measures [20–22].
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Lena
Contact Lena, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack